We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$21.4B
AUM Growth
+$1.5B
Cap. Flow
+$1.66B
Cap. Flow %
7.75%
Top 10 Hldgs %
50.4%
Holding
201
New
31
Increased
27
Reduced
32
Closed
37

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.41B
2
CHTR icon
Charter Communications
CHTR
+$462M
3
CBRE icon
CBRE Group
CBRE
+$375M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$314M
5
VMW
VMware, Inc
VMW
+$285M

Top Sells

Rank Stock Value
1
EFX icon
Equifax
EFX
+$249M
2
IQV icon
IQVIA
IQV
+$239M
3
BIIB icon
Biogen
BIIB
+$172M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$130M
5
TMO icon
Thermo Fisher Scientific
TMO
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 31.13%
2 Technology 23.99%
3 Financials 9.09%
4 Communication Services 6.05%
5 Industrials 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TAL icon
76
TAL Education Group
TAL
$6.28B
$12.4M 0.06%
+1,365,000
New +$9.57M
SLNO
77
DELISTED
Soleno Therapeutics
SLNO
$11.4M 0.05%
+388,000
New +$2.35M
CD
78
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$10.8M 0.05%
+1,300,000
New +$10.6M
CRNX icon
79
Crinetics Pharmaceuticals
CRNX
$8.99B
$10.8M 0.05%
+361,904
New +$7.46M
SCRM
80
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
$10.5M 0.05%
1,000,000
– –
VYGR icon
81
Voyager Therapeutics
VYGR
$209M
$10M 0.05%
1,292,000
– –
AXSM icon
82
Axsome Therapeutics
AXSM
$10.9B
$8.78M 0.04%
125,653
-147,147
-54% -$11M
RIO icon
83
Rio Tinto
RIO
$171B
$8.75M 0.04%
137,500
– –
LBPH
84
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$8.68M 0.04%
1,560,500
+560,500
+56% +$3.61M
APLS
85
DELISTED
Apellis Pharmaceuticals
APLS
$7.38M 0.03%
194,053
+154,000
+384% +$6.76M
SLAM
86
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$6.15M 0.03%
570,396
– –
VNET
87
VNET Group
VNET
$1.91B
$5.56M 0.03%
1,775,000
– –
GHIX
88
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
$5.2M 0.02%
500,000
– –
GOSS icon
89
Gossamer Bio
GOSS
$75.6M
$5.11M 0.02%
+6,130,272
New +$7.06M
NDAQ icon
90
Nasdaq
NDAQ
$54.9B
$4.98M 0.02%
+102,500
New +$5.19M
FRXB
91
DELISTED
Forest Road Acquisition Corp. II
FRXB
$4.15M 0.02%
400,000
– –
IVCP
92
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$3.19M 0.01%
300,000
– –
BACA
93
DELISTED
Berenson Acquisition Corp. I
BACA
$2.96M 0.01%
285,715
– –
VERV
94
DELISTED
Verve Therapeutics
VERV
$2.8M 0.01%
+211,293
New +$3.4M
TVRD
95
Tvardi Therapeutics
TVRD
$24.8M
$2.8M 0.01%
46,294
– –
TVTX icon
96
Travere Therapeutics
TVTX
$6.19B
$2.43M 0.01%
+271,517
New +$3.83M
ARYD
97
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$2.17M 0.01%
200,000
– –
MTAL
98
DELISTED
Metals Acquisition
MTAL
$1.89M 0.01%
+157,500
New +$1.76M
MTAL.WS
99
DELISTED
Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share
MTAL.WS
$1.66M 0.01%
825,000
– –
GATE
100
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$1.57M 0.01%
150,000
– –
2 3
4
5 6

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q3 2023 Portfolio in Review

As of Q3 2023, Thomas Steyer held 201 positions worth $21.4B, up 7.5% from $19.9B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Thomas Steyer deployed $1.66B of net new capital in Q3 2023, opening 31 new positions and adding to 27 existing holdings. Its largest new stake was Charter Communications: 1,111,341 shares worth $489M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was IQVIA, an estimated $239M trimmed.

  • Thomas Steyer's largest Q3 2023 buy was Charter Communications: 1,111,341 shares worth $489M.
  • Thomas Steyer added most to Activision Blizzard in Q3 2023, an estimated $1.41B increase.
  • Thomas Steyer's biggest Q3 2023 reduction was IQVIA, cutting an estimated $239M.
  • Thomas Steyer fully exited Equifax in Q3 2023, selling an estimated $249M.
  • Thomas Steyer's ten largest holdings make up 50% of its $21.4B portfolio in Q3 2023.
  • Thomas Steyer opened 31 new positions and closed 37 in Q3 2023.
  • Thomas Steyer's portfolio value rose 7.5% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.